Comparison of Community and Hospital Antibiotic Use Practices, Susceptibility and ResisTance and Determinants of Care Seeking Among Patients With Urinary Tract Infections (CAST-UTI)

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

1. General objective This pilot study aims to compare the prevalence of resistance in bacteria causing UTIs among patients seeking care outside the hospital settings (CDROs) to the WHO-GLASS data. 2. Specific objectives 2-1 Primary objectives: * Determine the resistance profiles of uropathogens and carriage strains from patients with uncomplicated UTIs attending community drug retail outlets (CDRO's) and in hospitals\*. * Compare the resistance profiles of the uropathogens from patients with uncomplicated UTIs attending CDROs and hospitals to those in the WHO-GLASS database. * Explore the patient pathway and its impact on antibiotic use among patients presenting to CDROs and hospitals with uncomplicated UTIs. * Determine the appropriateness of antimicrobial use in the treatment of uncomplicated UTIs among patients presenting to CDROs and hospitals 2-2 Secondary objectives: * Compare resistance profiles among the uropathogens from patients from two neighbourhoods in Kampala. * Examine environmental samples between the study sites to determine the presence of antibiotic residues and AMR two neighbourhoods in Kampala.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Must have one or more of the following clinical presentations regardless of age:

⁃ acute (\< 2 weeks) dysuria. increased urinary urgency and frequency, irritation, discharge. increased lower abdominal pain or discomfort and sometimes gross haematuria.

• In elderly patients with pre-existing urinary symptoms: increased acute urinary changes.

Locations
Other Locations
Uganda
Infectious Diseases Research Collaboration (IDRC), Uganda
RECRUITING
Kampala
Contact Information
Primary
Catrin E Moore, DPhil, MBA, MSc, BSc, FRSB, FI
camoore@sgul.ac.uk
+44 2087252823
Backup
Henry Kajumbula, PhD
henrykajumbula427@gmail.com
+256 41 4530 020
Time Frame
Start Date: 2024-10-06
Estimated Completion Date: 2026-04-30
Participants
Target number of participants: 3000
Treatments
Namuwongo community
The Namuwongo informal settlement is located in the urban area of Kampala, Uganda. An estimated 70% of residents in the informal settlement routinely (within the last month) use antibiotics. Houses are overcrowded with residents paying to use public toilets.~The investigators are recruiting from community drug retail outlets and the outpatient department of Kitsugu health centre located next to Namuwongo.
Muyenga community
The Muyenga and Bukasa neighbourhoods are also located in the urban area of Kampala, Uganda, but is more affluent than the Namuwongo informal settlement. Residents in Muyenga can afford more expensive treatments at community drug retail outlets (CDROs)/clinics.~The investigators are recruiting from community drug retail outlets and the outpatient department of Naguru hospital located next to Muyenga and Bukasa neighbourhoods.
Related Therapeutic Areas
Sponsors
Collaborators: Makerere University, Infectious Diseases Research Collaboration, Uganda
Leads: St George's, University of London

This content was sourced from clinicaltrials.gov